System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Dimitrios Farmakis is an expert in Cardiology at University General Hospital Attikon (Greece). As of October 2026, ScienceLeadR ranks Dimitrios Farmakis in the top 1% of experts worldwide for Heart Failure and Anemia. Dimitrios Farmakis has authored 382 publications, the most recent in 2026, and is an investigator in 7 clinical trials, 1 of them ongoing. SLR score: 1,285 (community average: 125). How the SLR is computed.

LeadR Profile

Dimitrios Farmakis University General Hospital Attikon Greece
1 285 ScienceLeadR Reputation 1285

Unlock

Register Login
Network Map

Cardiology

Subspecialties: Hematology - Biochemistry - Oncology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2003 - 2026
Source: PubMed

National and Kapodistrian University of Athens

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 382

Citations

Citations: 33 339 1st author: 77 Last author: 30 Unique author: 3

Main journals

Eur J Heart Fail 60
Eur Heart J 23
Int J Cardiol 23
ESC Heart Fail 12
Heart Fail Rev 11

Best Journals

Eur Heart J 13
Circulation 2
N Engl J Med 2

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Heart failure with supranormal ejection fraction: is it the new Ariadne's string?
PMID 42928386 — exercise, heart valve diseases, heart diseases, heart failure, heart, phenotype, therapeutics		Heart Fail Rev20260
Educational needs in cardio-oncology: an international survey by the COOL group of the ESC council of cardio-oncology.
PMID 42927265 — cardiology, cardiologists, education, cardio-oncology		Eur Heart J Open20260
Long-Term Cardiovascular Care After Cytokine Release Syndrome: JACC CardioOncology Primer.
PMID 42904621 — cytokines, cytokine release syndrome, survivorship, cardio-oncology		JACC CardioOncol20260
The Role of Soluble Suppression of Tumorigenicity-2 and Galectin-3 in Heart Failure With Preserved Ejection Fraction: A Scoping Review of the Literature.
PMID 42859718 — galectins, fibrosis, heart failure, heart, heart failure, diastolic, galectin 3, biomarkers, diagnosis, prognosis		Rev Cardiovasc Med20260
Updating risk stratification for CAR-T cell-related cardiovascular toxicity: from CART-7 to CART-8.
PMID 42717801 — cells, cardiology, t-lymphocytes, car-t cell		Eur Heart J Top journal20260

Clinical Studies 7

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

N/A 4
Phase 2 1
Phase 3 1
Phase 4 1

By status:

Completed 4
Unknown 2
Recruiting 1

By type:

Interventional 6
Observational 1

By Monocentric/Multicentric:

monocentric 3
multicentric2to4 0
multicentric5to9 1
multicentricup10 3

Main Topics

Ongoing Clinical Trials

Ongoing trial started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Artificial Intelligence for Automated Clinical Data Exploration From Electronic Medical Records (CardioMining AI)
NCT05176769 — intelligence, electronic health records, machine learning, records, learning, artificial intelligence, medical records, electronic medical record, digital health		N/ARecruiting2022

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS